The INCA trial: a multicenter, randomized, phase II, open-label clinical trial to evaluate the combination therapy with Ipilimumab plus Nivolumab versus Chemotherapy (Pemetrexate-Cisplatin) in patients with Advanced non-squamous NSCLC naive to treatment. PPCR [Internet]. 2018 Jul. 25 [cited 2024 Nov. 22];4(1):6-13. Available from: https://journal.ppcr.org/index.php/ppcrjournal/article/view/62